Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis

Accumulating evidence indicates that ATP-binding cassette (ABC) transporter ABCG2 plays a key role in regulating the cellular accumulation of porphyrin derivatives in cancer cells and thereby affects the efficacy of photodynamic therapy and photodynamic diagnosis. The activity of porphyrin efflux ca...

Full description

Saved in:
Bibliographic Details
Main Authors: Toshihisa Ishikawa, Hiroshi Nakagawa, Yuichiro Hagiya, Naosuke Nonoguchi, Shin-ichi Miyatake, Toshihiko Kuroiwa
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Advances in Pharmacological Sciences
Online Access:http://dx.doi.org/10.1155/2010/587306
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549986078818304
author Toshihisa Ishikawa
Hiroshi Nakagawa
Yuichiro Hagiya
Naosuke Nonoguchi
Shin-ichi Miyatake
Toshihiko Kuroiwa
author_facet Toshihisa Ishikawa
Hiroshi Nakagawa
Yuichiro Hagiya
Naosuke Nonoguchi
Shin-ichi Miyatake
Toshihiko Kuroiwa
author_sort Toshihisa Ishikawa
collection DOAJ
description Accumulating evidence indicates that ATP-binding cassette (ABC) transporter ABCG2 plays a key role in regulating the cellular accumulation of porphyrin derivatives in cancer cells and thereby affects the efficacy of photodynamic therapy and photodynamic diagnosis. The activity of porphyrin efflux can be affected by genetic polymorphisms in the ABCG2 gene. On the other hand, Nrf2, an NF-E2-related transcription factor, has been shown to be involved in oxidative stress-mediated induction of the ABCG2 gene. Since patients have demonstrated individual differences in their response to photodynamic therapy, transcriptional activation and/or genetic polymorphisms of the ABCG2 gene in cancer cells may affect patients' responses to photodynamic therapy. Protein kinase inhibitors, including imatinib mesylate and gefitinib, are suggested to potentially enhance the efficacy of photodynamic therapy by blocking ABCG2-mediated porphyrin efflux from cancer cells. This review article provides an overview on the role of human ABC transporter ABCG2 in photodynamic therapy and photodynamic diagnosis.
format Article
id doaj-art-37f859982f5040778a47e85d96eec195
institution Kabale University
issn 1687-6334
1687-6342
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Advances in Pharmacological Sciences
spelling doaj-art-37f859982f5040778a47e85d96eec1952025-02-03T06:07:57ZengWileyAdvances in Pharmacological Sciences1687-63341687-63422010-01-01201010.1155/2010/587306587306Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic DiagnosisToshihisa Ishikawa0Hiroshi Nakagawa1Yuichiro Hagiya2Naosuke Nonoguchi3Shin-ichi Miyatake4Toshihiko Kuroiwa5Omics Science Center, RIKEN Yokohama Institute, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, JapanGraduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Yokohama 226-8501, JapanGraduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Yokohama 226-8501, JapanDepartment of Neurosurgery, Osaka Medical College, Osaka 569-8686, JapanDepartment of Neurosurgery, Osaka Medical College, Osaka 569-8686, JapanDepartment of Neurosurgery, Osaka Medical College, Osaka 569-8686, JapanAccumulating evidence indicates that ATP-binding cassette (ABC) transporter ABCG2 plays a key role in regulating the cellular accumulation of porphyrin derivatives in cancer cells and thereby affects the efficacy of photodynamic therapy and photodynamic diagnosis. The activity of porphyrin efflux can be affected by genetic polymorphisms in the ABCG2 gene. On the other hand, Nrf2, an NF-E2-related transcription factor, has been shown to be involved in oxidative stress-mediated induction of the ABCG2 gene. Since patients have demonstrated individual differences in their response to photodynamic therapy, transcriptional activation and/or genetic polymorphisms of the ABCG2 gene in cancer cells may affect patients' responses to photodynamic therapy. Protein kinase inhibitors, including imatinib mesylate and gefitinib, are suggested to potentially enhance the efficacy of photodynamic therapy by blocking ABCG2-mediated porphyrin efflux from cancer cells. This review article provides an overview on the role of human ABC transporter ABCG2 in photodynamic therapy and photodynamic diagnosis.http://dx.doi.org/10.1155/2010/587306
spellingShingle Toshihisa Ishikawa
Hiroshi Nakagawa
Yuichiro Hagiya
Naosuke Nonoguchi
Shin-ichi Miyatake
Toshihiko Kuroiwa
Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis
Advances in Pharmacological Sciences
title Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis
title_full Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis
title_fullStr Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis
title_full_unstemmed Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis
title_short Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis
title_sort key role of human abc transporter abcg2 in photodynamic therapy and photodynamic diagnosis
url http://dx.doi.org/10.1155/2010/587306
work_keys_str_mv AT toshihisaishikawa keyroleofhumanabctransporterabcg2inphotodynamictherapyandphotodynamicdiagnosis
AT hiroshinakagawa keyroleofhumanabctransporterabcg2inphotodynamictherapyandphotodynamicdiagnosis
AT yuichirohagiya keyroleofhumanabctransporterabcg2inphotodynamictherapyandphotodynamicdiagnosis
AT naosukenonoguchi keyroleofhumanabctransporterabcg2inphotodynamictherapyandphotodynamicdiagnosis
AT shinichimiyatake keyroleofhumanabctransporterabcg2inphotodynamictherapyandphotodynamicdiagnosis
AT toshihikokuroiwa keyroleofhumanabctransporterabcg2inphotodynamictherapyandphotodynamicdiagnosis